%20from%20quentin.png)
Dr. Luke Nordquist founded the Urology Cancer Center (UCC) in 2010 with the primary vision of becoming a Center of Excellence and Medical Destination for patients suffering with Prostate and other Urologic Cancers. Our Globally recognized research program provides access to the most effective and individualized treatment options available today. Patients from over 40 states, coast to coast, call the Urology Cancer Center home for their cancer care.
Every patient has a dedicated team of professionals with one mission: to provide each patient with unsurpassed personalized cancer care accomplished through deep heartfelt compassion, extensive and comprehensible education, the most proficient cancer management, and an unparalleled focus on improving survival and quality of life.
We utilize a unique team approach: Dr. Luke and his Clinical Team, Research Coordinators, Treatment Nurses, Pharmacy, Scheduling and Financial staff work simultaneously during a patient’s visit to ensure delivery of the most accurate, personalized, efficient and expert care.
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Suspendisse varius enim in eros elementum tristique. Duis cursus, mi quis viverra ornare, eros dolor interdum nulla, ut commodo diam libero vitae erat. Aenean faucibus nibh et justo cursus id rutrum lorem imperdiet. Nunc ut sem vitae risus tristique posuere.
We understand the financial burdens cancer may cause a patient and their family. We have highly trained and compassionate staff when it comes helping you choose the most appropriate insurance plans and obtaining assistance to minimize your out- of-pocket costs.
A WRONG DIAGNOSIS ALMOST COST VINCE HIS LIFE
In 2018, Vince showed up at the Urology Cancer Center from out of state for a second opinion from Dr. Nordquist regarding his recently diagnosed kidney cancer. He was suffering with pain and dropping weight. His kidney was biopsied and confirmed he did indeed have kidney cancer. His CT scans showed multiple areas of cancer in his bones also. It was assumed by his initial oncologist that he had metastatic kidney cancer that had spread to the bones and advised him to start treatment for kidney cancer.
However, during his initial visit, Dr. Nordquist found this to be an unusual presentation for kidney cancer. Although kidney cancer does spread to the bone it typically occurs after first spreading to other organs. In addition, given the small size of Vince’s kidney cancer it was unlikely that the kidney cancer would have even spread at all. He realized Vince had not had a recent PSA blood test to screen for prostate cancer, which commonly spreads to bone. A normal PSA value is less than 4 and Vince’s PSA was more than 5,000. What Vince actually had was a small curable kidney cancer that was treated with an outpatient freezing procedure and prostate cancer that had spread to the bone.
Although still not curable prostate cancer has a much better prognosis and patients can live much longer with appropriate treatment than they can with metastatic kidney cancer. Within less than 6 months Vince’s PSA was less than 1 and he continues to do well today without cancer symptoms.
- Vince
Ray's Dying Wish
Ray was an amazing man full of life. He had been a patient with Dr. Luke since 2011. Ray had advanced prostate cancer that had spread throughout his body. He did well for several years and remained active. He participated in several research trials with Dr. Luke that had prolonged his life. In 2015, his story took a turn for worse when he was diagnosed with a second cancer, lung cancer, which later spread to his brain. He continued to fight like a champion undergoing treatment both his prostate cancer with Dr. Luke and for his lung cancer through another Omaha cancer physician.
In late 2019, what turned out to be his last visit with Dr. Luke he said he wanted a ride in Dr. Luke's Ferrari before he died. Dr. Luke said "Ok let's do it". With that Dr. Luke stopped his clinic and with the help of his staff Ray was loaded into the passenger seat and they spent the next 30 minutes speeding around west Omaha. When they pulled back up to the center Ray had a smile from ear to ear! Ray passed a few days later.
BRAVERY TO BE FIRST IN WORLD ON A CLINICAL TRIAL, GIVES NEW LIFE
Bill, a former PE teacher, was diagnosed with Prostate Cancer at the young age of 54. Roughly seven years into his cancer battle with no FDA approved treatments remaining, Bill was considering hospice and likely had only weeks to live. He commented, “I’m ready for the Good Lord to take me home”. He was wheelchair bound and requiring around the clock pain medications. He rarely left his home except to go to doctor appointments. After long conversations regarding Bill and his wife’s wishes, he chose to consider a clinical research trial and fight one more time.
In 2018, Bill became the first patient in the world to enroll on a global clinical research trial at the Urology Cancer Center, with a novel class of medicine called a radiopharmaceutical. In 2020, nearly 3 years later Bill has no significant disease present. He is no longer in a wheel chair and is back to working out at the gym daily with no pain. He has returned to his love of kayaking. “I’m living life and every day is just like a brand-new day to me, “ said Bill.
NEW HOPE, NEW LIFE THROUGH INNOVATIVE TREATMENT
Eric was first diagnosed with a very aggressive form of prostate cancer in July 2008. Despite being aggressive, his cancer was thought to be confined to his prostate and potentially curable. Following curative treatment radiation, Eric unfortunately had a cancer recurrence and was being managed at Mayo Clinic. Although he was under the impression he had minimal treatment options remaining, he was referred to the Urology Cancer Center in 2019 to see what clinical trial options might be available. He was enrolled on a clinical research trial and nearly 2 years later he remains with minimal detectable disease and was recently able to take a trip to Hawaii.
“We arrived at Urology Cancer Center 18 months ago after a strong referral from Mayo Clinic to apply for the Lutetium-PSMA-617 Clinical Study. We were very pleased when we were accepted into the study. Dr. Luke and his team have done an exceptional job of helping us manage our care through this Clinical Study. The staff is always very friendly and helpful. We are so pleased to be a patient under Dr. Luke’s care. Because of his expert care, we have enjoyed traveling and spending more time with our grandkids in our retirement.”
KURT'S OPTIMISM & BRAVERY BEATS THE ODDS
In 2007, Kurt at age 53 was diagnosed with late-stage prostate cancer. It had already spread throughout his bones. His cancer was discovered during routine Prostate Cancer screening with an initial PSA of over 800 (normal <4). He was confirmed to have an aggressive prostate cancer. His first oncologist told him to get his affairs in order because he only had a few years to live at most. He quickly progressed on first- and second-line therapies at which time he met with Dr. Nordquist for a second opinion.
During his visit, Dr. Nordquist discussed a promising Phase I/II clinical research trial as a potential treatment option. Kurt had limited financial resources and decided to give it a try. On the trial his treatment was given for free. This treatment controlled Kurt’s cancer for more than 4 years. His treatments have been changed several times since then as new treatments continue to evolve. Now over 13 years after his initial diagnosis, Kurt is still enjoying the outdoors and doing side projects around his house.
“I’ve been seeing Dr. Luke for over 13 years and I think I’m 10 years on borrowed time. When I was first diagnosed and first saw Dr. Luke, my PSA was over 800. I’m still here and I don’t believe I’m still here and it’s all because of Dr. Luke and the UCC team… they are the angels in my life, they are the best!”
Precision Cancer Research (PCR) is a Network of Community Cancer Research Centers founded by Dr. Nordquist and headquartered in Omaha. PCR expands the cancer research success that Dr. Luke has created at the Urology Cancer Center to other cancer centers who currently have minimal to no research program. The mission of PCR is to expand access to cancer patients nationwide who currently do not have access to cutting edge cancer treatments. PCR is currently engaged with more than 40 cancer centers from coast to coast.
The Omaha Cancer Foundation is a 501c3 charitable organization with the mission of raising funds and awareness efforts in underserved regions of Africa. Dr. Luke and his team have developed a relationship with the Kilimanjaro Christian Medical Center Cancer Team and are assisting them with the construction of a housing facility for cancer patients while receiving treatment and meet with them regularly with efforts to create cancer research program in Tanzania.
Your Team Foundation is a 501c3 charitable organization with the mission to utilize the giving and volunteer spirit of the Omaha community to assist local cancer patients with unmet needs. Your Team raises funds to assist with non-medical financial concerns of cancer patients and also arranges volunteers to provide services to local cancer patients from car and house repairs to lawn work. Our slogan is “Just Ask!”
Your UCC Cancer Team brings all of the FDA approved standard of care treatments to the fight against your cancer. However, more than ANY other cancer center in the U.S., the UCC Cancer Team has the most access to the latest cutting edge clinical research trials providing potentially life-saving treatments. Cancer research is the only way to discover and utilize new treatments for cancer patients. The Urology Center's Research Team is Globally recognized as a leader by scientific thought leaders, patients and pharmaceutical companies Contact us today for the expert 2nd opinion that you deserve to see how we can bring the best fight against your cancer!
Start Your Care
